(E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide

C103H118Cl2F2N12O8 — CID 157278888

IUPAC(E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide
SMILESNCC[C@@H]1N[C@H](CNC(=O)/C=C/c2ccc(F)cc2F)CCN(CC(c2ccccc2)c2ccccc2)C1=O.O=C(/C=C/c1ccc(Cl)cc1)NC[C@@H]1CCN(CC(c2ccccc2)c2ccccc2)C(=O)[C@H](CCN2CCOCC2)N1.O=C(/C=C/c1ccc(Cl)cc1)NC[C@@H]1CCN(CC(c2ccccc2)c2ccccc2)C(=O)[C@H](CNC(=O)C2CCCCC2)N1
InChIInChI=1S/C37H43ClN4O3.C35H41ClN4O3.C31H34F2N4O2/c38-31-19-16-27(17-20-31)18-21-35(43)39-24-32-22-23-42(26-33(28-10-4-1-5-11-28)29-12-6-2-7-13-29)37(45)34(41-32)25-40-36(44)30-14-8-3-9-15-30;36-30-14-11-27(12-15-30)13-16-34(41)37-25-31-17-20-40(35(42)33(38-31)18-19-39-21-23-43-24-22-39)26-32(28-7-3-1-4-8-28)29-9-5-2-6-10-29;32-25-13-11-24(28(33)19-25)12-14-30(38)35-20-26-16-18-37(31(39)29(36-26)15-17-34)21-27(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-2,4-7,10-13,16-21,30,32-34,41H,3,8-9,14-15,22-26H2,(H,39,43)(H,40,44);1-16,31-33,38H,17-26H2,(H,37,41);1-14,19,26-27,29,36H,15-18,20-21,34H2,(H,35,38)/b21-18+;16-13+;14-12+/t32-,34-;31-,33-;26-,29-/m000/s1
InChIKeyAZKUNMBPEHGRRE-ZVGLUDGBSA-N
MW1761.05 g/mol
LogP13.97
Rot. Bonds32

About (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide

(E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide (PubChem CID 157278888) has the molecular formula C103H118Cl2F2N12O8 and a molecular weight of 1761.05 g/mol. Its IUPAC name is (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide.

Molecular Properties

Compound Name(E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide
PubChem CID157278888
Molecular FormulaC103H118Cl2F2N12O8
Molecular Weight1761.05 g/mol
Exact Mass1758.85
IUPAC Name(E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide
SMILESNCC[C@@H]1N[C@H](CNC(=O)/C=C/c2ccc(F)cc2F)CCN(CC(c2ccccc2)c2ccccc2)C1=O.O=C(/C=C/c1ccc(Cl)cc1)NC[C@@H]1CCN(CC(c2ccccc2)c2ccccc2)C(=O)[C@H](CCN2CCOCC2)N1.O=C(/C=C/c1ccc(Cl)cc1)NC[C@@H]1CCN(CC(c2ccccc2)c2ccccc2)C(=O)[C@H](CNC(=O)C2CCCCC2)N1
InChIInChI=1S/C37H43ClN4O3.C35H41ClN4O3.C31H34F2N4O2/c38-31-19-16-27(17-20-31)18-21-35(43)39-24-32-22-23-42(26-33(28-10-4-1-5-11-28)29-12-6-2-7-13-29)37(45)34(41-32)25-40-36(44)30-14-8-3-9-15-30;36-30-14-11-27(12-15-30)13-16-34(41)37-25-31-17-20-40(35(42)33(38-31)18-19-39-21-23-43-24-22-39)26-32(28-7-3-1-4-8-28)29-9-5-2-6-10-29;32-25-13-11-24(28(33)19-25)12-14-30(38)35-20-26-16-18-37(31(39)29(36-26)15-17-34)21-27(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-2,4-7,10-13,16-21,30,32-34,41H,3,8-9,14-15,22-26H2,(H,39,43)(H,40,44);1-16,31-33,38H,17-26H2,(H,37,41);1-14,19,26-27,29,36H,15-18,20-21,34H2,(H,35,38)/b21-18+;16-13+;14-12+/t32-,34-;31-,33-;26-,29-/m000/s1
InChIKeyAZKUNMBPEHGRRE-ZVGLUDGBSA-N
XLogP13.97
TPSA251.91 Ų
H-Bond Donors8
H-Bond Acceptors13
Rotatable Bonds32
Heavy Atoms127
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001761.05
LogP ≤ 513.97
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide?
The IUPAC name of (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide (CID 157278888) is (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide.
What is the SMILES notation for (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide?
The canonical SMILES for (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide is NCC[C@@H]1N[C@H](CNC(=O)/C=C/c2ccc(F)cc2F)CCN(CC(c2ccccc2)c2ccccc2)C1=O.O=C(/C=C/c1ccc(Cl)cc1)NC[C@@H]1CCN(CC(c2ccccc2)c2ccccc2)C(=O)[C@H](CCN2CCOCC2)N1.O=C(/C=C/c1ccc(Cl)cc1)NC[C@@H]1CCN(CC(c2ccccc2)c2ccccc2)C(=O)[C@H](CNC(=O)C2CCCCC2)N1.
What is the InChIKey of (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide?
The InChIKey is AZKUNMBPEHGRRE-ZVGLUDGBSA-N. The full InChI is InChI=1S/C37H43ClN4O3.C35H41ClN4O3.C31H34F2N4O2/c38-31-19-16-27(17-20-31)18-21-35(43)39-24-32-22-23-42(26-33(28-10-4-1-5-11-28)29-12-6-2-7-13-29)37(45)34(41-32)25-40-36(44)30-14-8-3-9-15-30;36-30-14-11-27(12-15-30)13-16-34(41)37-25-31-17-20-40(35(42)33(38-31)18-19-39-21-23-43-24-22-39)26-32(28-7-3-1-4-8-28)29-9-5-2-6-10-29;32-25-13-11-24(28(33)19-25)12-14-30(38)35-20-26-16-18-37(31(39)29(36-26)15-17-34)21-27(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-2,4-7,10-13,16-21,30,32-34,41H,3,8-9,14-15,22-26H2,(H,39,43)(H,40,44);1-16,31-33,38H,17-26H2,(H,37,41);1-14,19,26-27,29,36H,15-18,20-21,34H2,(H,35,38)/b21-18+;16-13+;14-12+/t32-,34-;31-,33-;26-,29-/m000/s1.
What are the key properties of (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide?
(E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide has a molecular weight of 1761.05 g/mol, XLogP of 13.97, 32 rotatable bonds, 8 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-N-[[(3S,5S)-3-(2-aminoethyl)-1-(2,2-diphenylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]-3-(2,4-difluorophenyl)prop-2-enamide;(E)-3-(4-chlorophenyl)-N-[[(3S,5S)-1-(2,2-diphenylethyl)-3-(2-morpholin-4-ylethyl)-2-oxo-1,4-diazepan-5-yl]methyl]prop-2-enamide;N-[[(2S,7S)-7-[[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]methyl]-4-(2,2-diphenylethyl)-3-oxo-1,4-diazepan-2-yl]methyl]cyclohexanecarboxamide is sourced from PubChem (CID 157278888), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).